Novartis AG Common Stock (NVS)
EBITDA Margin
41.17%
Quarterly · Period ending:
NVS EBITDA Margin
Latest reported41.17%period ending
Latest reported41.17%period ending
NVS Quarterly EBITDA Margin (100.00% → 41.17%)
Quarterly ebitda margin
High-resolution chart · PNG
NVS ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 41.1716% | |
| 40.003% | |
| 38.0408% | |
| 40.6812% | |
| 40.9544% | |
| 42.812% | |
| 38.2652% | |
| 42.6207% | |
| 40.7784% | |
| 38.4818% | |
| 35.5129% | |
| 40.3986% | |
| 39.1486% | |
| 41.5497% | |
| 29.8617% | |
| 34.3875% | |
| 30.9209% | |
| 33.3619% | |
| 138.1157% | |
| 36.5452% | |
| 38.7468% | |
| 34.2603% | |
| 33.5917% | |
| 34.7185% | |
| 36.233% | |
| 33.6009% | |
| 30.6622% | |
| 32.2464% | |
| 32.3104% | |
| 33.2344% | |
| 25.4464% | |
| 33.7695% | |
| 82.4938% | |
| 31.9179% | |
| 30.2112% | |
| 32.3905% | |
| 20.0656% | |
| 18.0484% | |
| 24.4169% | |
| 32.0557% | |
| 29.6474% | |
| 33.0737% | |
| 20.4155% | |
| 29.4594% | |
| 29.6914% | |
| 33.9207% | |
| 31.1966% | |
| 36.6992% | |
| 32.1743% | |
| 31.6399% | |
| 24.3702% | |
| 29.095% | |
| 32.5828% | |
| 29.6213% | |
| 26.407% | |
| 29.8526% | |
| 31.0295% | |
| 28.5129% | |
| 21.3857% | |
| 30.1583% | |
| 31.8654% | |
| 33.413% | |
| 23.3131% | |
| 32.9095% | |
| 31.8597% | |
| 35.8045% | |
| 26.1468% | |
| 29.0345% | |
| 29.1287% | |
| 29.5184% | |
| 29.5323% | |
| 30.6165% | |
| 29.9272% | |
| 30.5599% | |
| 20.0079% | |
| 30.5052% | |
| 27.9255% | |
| 30.6699% | |
| 29.3272% | |
| 28.1693% | |
| 29.0668% | |
| 30.5031% | |
| 31.7834% | |
| 28.107% | |
| 27.23% | |
| 26.7675% | |
| 32.6603% | |
| 29.0067% | |
| 30.2596% | |
| 27.1577% | |
| 35.0223% | |
| 29.4686% | |
| 28.2444% | |
| 28.9285% | |
| 24.1896% | |
| 29.3734% | |
| 25.7592% | |
| 100% | |
| -190.833% | |
| 100% |